SYMBIOSYS financials
A multi-period view of the public annual-account figures reported for SYMBIOSYS, with comparable measures and links to available source documents.
Company overviewRegistry number
0885032453
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for SYMBIOSYS
2025 versus 2024
- Operating line
- €38,094
- EBITDA
- €36,927
- Total assets
- €95,553
- Equity
- €66,097
+1.5%
+1.4%
-8.6%
-25.4%
EBITDA margin +96.9% · Equity ratio +69.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €38,094 | €36,927 | €95,553 | €66,097 | - |
| 202430 Sept 2024 | €37,546 | €36,414 | €104,496 | €88,640 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.